PYC Therapeutics Ltd
(ASX) PYC
PYC Therapeutics Ltd Financials at a Glance
Market Cap
$1.16B
Revenue (TTM)
$36.65M
Net Income (TTM)
$95.76M
EPS (TTM)
$-0.08
P/E Ratio
-14.17
Dividend
$0.00
Beta (Volatility)
-0.09 (Low)
Dividend
$0.00
Beta (Volatility)
-0.09 (Low)
Price
$1.18
Volume
822,959
Open
$1.20
Price
$1.18
Volume
822,959
Open
$1.20
Previous Close
$1.18
Daily Range
$1.13 - $1.20
52-Week Range
$0.85 - $1.75
Dividend
$0.00
Beta (Volatility)
-0.09 (Low)
Price
$1.18
Volume
822,959
Open
$1.20
Previous Close
$1.18
Daily Range
$1.13 - $1.20
52-Week Range
$0.85 - $1.75
PYC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout PYC Therapeutics Ltd
Industry
Biotechnology
Sector
Health CareCEO
Rohan Hockings
Website
www.pyctx.comHeadquarters
Nedlands, WA 6009, AU
PYC Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-5%
Net Income Margin
-4%
Return on Equity
-47%
Return on Capital
-41%
Return on Assets
-30%
Earnings Yield
-7.06%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.16B
Shares Outstanding
983.26M
Volume
822.96K
Short Interest
0.00%
Avg. Volume
1.37M
Financials (TTM)
Gross Profit
$23.49M
Operating Income
$53.63M
EBITDA
$52.88M
Operating Cash Flow
$51.56M
Capital Expenditure
$975.40K
Free Cash Flow
$52.54M
Cash & ST Invst.
$153.05M
Total Debt
$1.02M
PYC Therapeutics Ltd Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$302.80K
-103.5%
Gross Margin
0.00%
N/A
Market Cap
$1.16B
N/A
Market Cap/Employee
$50.23M
N/A
Employees
23
N/A
Net Income
$22.83M
-51.2%
EBITDA
$33.32M
-120.7%
Quarterly Fundamentals
Net Cash
$119.43M
+380.2%
Accounts Receivable
$32.59M
+275.8%
Inventory
$0.00
N/A
Long Term Debt
$873.86K
+297.6%
Short Term Debt
$390.15K
-39.9%
Return on Assets
-29.89%
N/A
Return on Invested Capital
-40.89%
N/A
Free Cash Flow
$31.45M
-341.8%
Operating Cash Flow
$31.21M
-356.3%